Lower plasma ApoA1 levels are found in Parkinson’s disease and associate with APOA1 genotype

BACKGROUND: The discovery of novel plasma-based biomarkers could lead to new approaches in the treatment of Parkinson’s disease (PD). Here we explore the role of plasma Apolipoprotein A1 (ApoA1) as a risk marker for PD and evaluate the influence of APOA1 promoter variation on plasma ApoA1 levels. ME...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mov Disord
Asıl Yazarlar: Swanson, Christine R., Li, Katherine, Unger, Travis L., Gallagher, Michael D., Van Deerlin, Vivianna M., Agarwal, Pinky, Leverenz, James, Roberts, John, Samii, Ali, Gross, Goldmann Rachel, Hurtig, Howard, Rick, Jacqueline, Weintraub, Daniel, Trojanowski, John Q., Zabetian, Cyrus, Chen-Plotkin, Alice S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362847/
https://ncbi.nlm.nih.gov/pubmed/25227208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26022
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller